Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.2 | 0.0 | 4.5 |
| Revenue growth | | -100.0% | |
| Cost of goods sold | 0.2 | 0.0 | 4.5 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Gross margin | 0.0% | | 0.7% |
| Research and development | 3.5 | 1.6 | 2.6 |
| General and administrative | 4.4 | 1.6 | 1.8 |
| EBIT | -7.9 | -3.2 | -4.5 |
| EBIT margin | -4354.4% | | -99.3% |
| Pre-tax income | -7.9 | -3.2 | -4.7 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% |
| Net income | -10.5 | -3.2 | -4.7 |
| Net margin | -5799.7% | | -104.8% |
| |
| Diluted EPS | ($2.43) | ($1.69) | ($2.47) |
| Shares outstanding (diluted) | 4.3 | 1.9 | 1.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|